Publicacións en colaboración con investigadores/as de University College London (45)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. A synthetic data generation system for myalgic encephalomyelitis/chronic fatigue syndrome questionnaires

    Scientific Reports, Vol. 13, Núm. 1

  3. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  4. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

  5. Unsupervised Cluster Analysis Reveals Distinct Subtypes of ME/CFS Patients Based on Peak Oxygen Consumption and SF-36 Scores

    Clinical Therapeutics, Vol. 45, Núm. 12, pp. 1228-1235

2022

  1. DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition

    Cancer Discovery, Vol. 12, Núm. 3, pp. 712-729

2021

  1. Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients

    Neuro-Oncology Advances, Vol. 3, Núm. 1

  2. Editorial: Personal Genomes: Accessing, Sharing, and Interpretation

    Frontiers in Genetics

  3. Executive functions in binge spectrum eating disorders with comorbid compulsive buying

    European Eating Disorders Review, Vol. 29, Núm. 6, pp. 854-867

  4. Metabolic dysregulation in older adults with depression and loneliness: The ATHLOS study

    Psychoneuroendocrinology, Vol. 123

  5. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

    Translational Psychiatry, Vol. 11, Núm. 1

  6. The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study

    Schizophrenia Research, Vol. 236, pp. 69-79

2020

  1. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 628-639

  2. Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529

  3. The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme

    Social Psychiatry and Psychiatric Epidemiology, Vol. 55, Núm. 5, pp. 645-657

2019

  1. HIV-1 molecular transmission clusters in nine European countries and Canada: Association with demographic and clinical factors

    BMC Medicine, Vol. 17, Núm. 1

  2. Visual attention mechanisms in happiness versus trustworthiness processing of facial expressions

    Quarterly Journal of Experimental Psychology, Vol. 72, Núm. 4, pp. 729-741

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

  2. Treated incidence of psychotic disorders in the multinational EU-GEI study

    JAMA Psychiatry, Vol. 75, Núm. 1, pp. 36-46